Key result
Female sex is linked to ~14-fold higher odds of no-reflow after primary PCI in young STEMI.
Why the study?
No-reflow phenomenon has prognostic value in STEMI but has not been extensively investigated in young patients.
What are the independent predictors of no-reflow phenomenon in young patients with STEMI undergoing primary PCI?
Observational (n=145)
What are the independent predictors of no-reflow phenomenon in young patients with STEMI undergoing primary PCI?
In young patients with STEMI undergoing primary PCI, female gender, longer pain-to-balloon time, high thrombus burden, and specific hematological indices predict no-reflow, while tirofiban use is protective.
Answers are grounded in this paper and cite their sources.
Supports risk stratification but should not change practice yet; leaves open whether targeting these factors improves outcomes in young STEMI.
No-reflow is of prognostic value in ST-segment elevation myocardial infarction (STEMI) but has not been extensively investigated in young patients. Young patients with STEMI admitted within 12 hours from symptom onset and treated by primary percutaneous coronary intervention (pPCI) were recruited. Patients were classified into 2 groups based on postintervention thrombolysis in myocardial infarction (TIMI) flow grade; no-reflow: TIMI flow grade 0, 1 or 2 (group 1; n = 27; 21 men, mean age: 42 ± 4 years); and angiographic success: TIMI flow grade 3 (group 2; n = 118; 110 men, mean age: 43 ± 4 years). Adjusted odds ratios were 13.79 for female gender (P < .001; confidence interval [CI] = 1.88-101.26), 2.09 for pain to balloon time (P < .017; CI = 1.14-3.812), 12.29 for high TIMI thrombus grade (P = .012; CI = 1.74-86.94), 0.04 for tirofiban use (P < .001; CI = 0.01-0.22), 5.19 for mean platelet volume (MPV; P < .001; CI = 2.44-11.01), and 1.008 for platelet-lymphocyte ratio (PLR; P = .034; CI = 1.001-1.016). In conclusion, female gender, pain to balloon time, high TIMI thrombus grade, tirofiban, MPV, and PLR were independent predictors of no-reflow in young patients with STEMI after pPCI.
No takes yet. Share an insight, caveat, or question.
Celık et al. (2015) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=145). Clinical and angiographic risk factors (e.g., female gender, pain to balloon time) vs. Patients without the respective risk factors was evaluated on No-reflow phenomenon (TIMI flow grade 0, 1 or 2) (OR 13.79, 95% CI 1.88-101.26, p=<0.001). Female gender, pain to balloon time, high TIMI thrombus grade, MPV, and PLR were independent predictors of no-reflow in young patients with STEMI after primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: